Cargando…
An abnormality in glucocorticoid receptor expression differentiates steroid responders from nonresponders in keloid disease
BACKGROUND: Glucocorticoids (GCs) are first‐line treatment for keloid disease (KD) but are limited by high incidence of resistance, recurrence and undesirable side‐effects. Identifying patient responsiveness early could guide therapy. METHODS: Nineteen patients with KD were recruited at week 0 (befo...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744777/ https://www.ncbi.nlm.nih.gov/pubmed/25712143 http://dx.doi.org/10.1111/bjd.13752 |